36C25020Q0026-000.docx

FedBizOpps Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field FedBizOpps Special Notice Rev. March 2010 Patient Coagulation Testing Kits 45409-1337 36C25020Q0026 N 334516 Department of Veterans Affairs Network Contracting Office 10 3140 Governor’s Place Blvd. Suite 210 Kettering OH 45409-1337 Angie Carpenter angie.carpenter@va.gov www.va.gov VA Homepage angie.carpenter@va.gov Procurement Point of Contact 36C25020Q0026

SPECIAL NOTICE

NOTICE OF INTENT TO SOLE SOURCE

Patient Coagulation Testing Kits

The Department of Veterans Affairs, Cleveland Veteran Affairs Medical Center (CLE VAMC), 10701 East Blvd, Cleveland Ohio, 44106, intends to solicit and negotiate with only one source under the authority of FAR 6.302-1(a)(2), “Only one responsible source and no other supplies or services will satisfy agency requirements.” The NAICS code is 334516 with a small business size standard of 1,000. The VA intends to solicit and negotiate with Werfen Group, Instrumentation Laboratory, 180 Hartwell Road, Bedford MA 017230, for cost for reportable test contract for coagulation testing.

This contract will be a Firm Fixed Price, Indefinite Delivery Indefinite Quantity Contract with a base year and four (4) option years, if applicable.

The coagulation test menu for the patient population shall consist of PT, APTT, Fibrinogen (Clauss), D-Dimer, D-Dimer HS (High Specificity), Heparin (anti-Xa), AT (anti-thrombin), HIT-ab (PF-4) automated latex immunoassay, Protein C & S, and Lupus anticoagulant. All testing shall be performed on the same instrument, allow pre-analytical analysis of the sample to ensure sample quality, and the analysis shall be FDA approved.

Other persons may identify their interest to respond to this requirement no later than Friday, 11 October 2019, at 4:00PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time. All inquiries must be submitted by email to Angie Carpenter at angie.carpenter@va.gov.

Enter “RFQ 36C25020Q0026 Patient Coagulation Testing” in the email subject line.